论文部分内容阅读
目的 :讨论硫普罗宁 (凯西莱 )治疗慢性乙型肝炎合并酒精性脂肪肝的疗效。方法 :随机分组 ,治疗组 46例 (均为男性 ,平均年龄 ( 4 3± 6)a)常规护肝治疗基础上加用硫普罗宁 2 0 0mg静脉滴注 ,qd× 4w。对照组 46例 (均为男性 ,平均年龄 ( 4 0± 8)a)应用常规护肝治疗。结果 :治疗组治疗后 4周肝功能指标SB、AST、GGT下降较对照组明显 (P <0 .0 5 )显效率 47 8%,总有效率89 1%,均优于对照组 ( 3 7 0 %,73 9%)。结论 :硫普罗宁治疗慢性乙型肝炎合并酒精性脂肪肝安全有效
Objective: To discuss the efficacy of tiopronin in treating chronic hepatitis B with alcoholic fatty liver disease. Methods: Forty-six patients (all male, average age (43 ± 6) a) were randomly divided into treatment group and control group. The treatment group was treated with 200 mg of tiopronin intravenously, qd × 4w. The control group of 46 patients (both men, mean age (40 ± 8) a) the application of conventional liver protection. Results: The decrease of SB, AST and GGT of the treatment group after 4 weeks of treatment was significantly (P <0. 05), the effective rate was 47.8% and the total effective rate was 89.1%, which were better than the control group 0%, 73 9%). Conclusion: It is safe and effective to use tiopronin in treating chronic hepatitis B with alcoholic fatty liver